CG Oncology, Inc.
CGON
$23.74
-$0.39-1.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -92.07% | -- | -95.36% | -97.27% | |
| Total Depreciation and Amortization | -100.00% | -- | 0.00% | 0.00% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -400.00% | |
| Total Other Non-Cash Items | 1,031.34% | -- | -330.64% | -365.87% | |
| Change in Net Operating Assets | 89.40% | -- | -2,351.74% | 98.24% | |
| Cash from Operations | -41.09% | -- | -225.72% | -114.45% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -28.45% | -- | -290.64% | 128.07% | |
| Cash from Investing | -29.80% | -- | -290.66% | 128.07% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 100.00% | -- | 56.18% | -- | |
| Issuance of Common Stock | 85,172.52% | -- | 597,561.76% | 77.03% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -99.28% | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 100.00% | -- | -- | -651.27% | |
| Cash from Financing | 7,814.57% | -- | 52,735.03% | -105.11% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 10,745.59% | -- | 179.13% | 63.30% | |